Learn More
Medchemexpress LLC XMD8-92 | 1234480-50-2 | 99.5% | C26H30N6O3 | 10 MM * 1 ML

Supplier: Medchemexpress LLC HY1444310MM/1ML
XMD8-92 is a potent inhibitor of ERK5 (BMK1) and BRD4, with Kds of 80 nM and 190 nM, respectively. It also inhibits DCAMKL2, PLK4, and TNK1. This compound exhibits anti-cancer activity and is intended for research use only.
- Potent ERK5 (BMK1) and BRD4 inhibitor
- Kds of 80 nM for BMK1 and 190 nM for BRD4
- Inhibits DCAMKL2, PLK4, and TNK1
- Exhibits anti-cancer activity
- For research use only
- Inhibits proliferation of HMEC and cancer cells
- Effectively inhibits BMK1 activation
- Induces PML's downstream effector, p21
- Significantly inhibits bFGF induced angiogenesis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.